OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 16,751 followers.

OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer https://t.co/UoQROa68eE

RT @lab_tres: Our paper about the role of OVOL2 in Anaplastic Thyroid Cancer Is finally out in @JournalofExper1! Here, we describe how it r…

RT @lab_tres: Our paper about the role of OVOL2 in Anaplastic Thyroid Cancer Is finally out in @JournalofExper1! Here, we describe how it r…

Our work on the role of OVOL2 transcriptional repressor in anaplastic thyroid carcinoma is finally out in @JournalofExper1! https://t.co/k1Q4JRGyIW Many thanks to all the coauthors! #thyroidcancer #anaplasticthyroidcancer #canceresearch #tRes_Lab @Ausl_RE

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.